News Research Predictive Risk Models Research and Evidence

Synthetic data boosts readmission prediction

April 20, 2026 By Matthew Solan 4 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter
Objective:

To evaluate the effectiveness of synthetic data in predicting 30-day hospital readmissions for patients with type 2 diabetes, COPD, and heart failure.

Key Findings:
  • Models using synthetic data outperformed those using original data alone, with AUROC values ranging from 0.91 to 0.95.
  • Gradient boosting achieved the highest performance in COPD and type 2 diabetes, while extreme gradient boosting excelled in heart failure.
  • Higher illness severity scores and greater comorbidity burden were key predictors of readmission.
  • Medication nonadherence significantly increased the odds of readmission across all conditions.
Interpretation:

Incorporating synthetic data and social/behavioral risk factors enhances predictive accuracy, supporting multidimensional risk prediction frameworks.

Limitations:
  • Single-center dataset without external validation may limit generalizability.
  • Potential underdocumentation of social determinants of health could affect findings.
  • Lack of evaluation of real-world implementation or cost-effectiveness limits practical application.
Conclusion:

The study highlights the potential of synthetic data in improving readmission prediction models, emphasizing the integration of social and behavioral factors.

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content